Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preserving antitrust.

A O'Neil-White, K Wilber

    HMO
    |April 8, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Physicians are seeking antitrust law exemptions, but the rise of provider-sponsored health plans may make these changes unnecessary. This analysis examines the evolving healthcare landscape and its impact on physician-led organizations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [HER-2 and TOP2A gene amplification in urinary bladder cancer].

    Verhandlungen der Deutschen Gesellschaft fur Pathologie·2003
    Same author

    [HER-2 and TOP 2A gene amplifications in urinary bladder carcinoma].

    Verhandlungen der Deutschen Gesellschaft fur Pathologie·2003
    Same author

    Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer.

    Journal of the National Cancer Institute·2001
    Same author

    High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.

    Cancer research·2001
    Same author

    Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas.

    AJNR. American journal of neuroradiology·2001
    Same author

    CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.

    The American journal of pathology·2001
    Same journal

    One voice: the GHAA/AMCRA merger.

    HMO·1995
    Same journal

    Comparing outcomes in managed care.

    HMO·1995
    Same journal

    Should the FDA regulate pharmacoeconomic studies?

    HMO·1995
    Same journal

    Hospice & managed care.

    HMO·1995
    Same journal

    Arms outstretched.

    HMO·1995
    Same journal

    The evolution of accreditation.

    HMO·1995
    See all related articles

    Area of Science:

    • Healthcare policy
    • Antitrust law
    • Health economics

    Background:

    • Organized medicine advocates for modifications to existing antitrust legislation.
    • Physician groups seek exemptions to navigate market dynamics.
    • The healthcare industry is experiencing a significant increase in provider-sponsored health plans.

    Purpose of the Study:

    • To evaluate the necessity of antitrust law exemptions for physicians.
    • To analyze the impact of increasing provider-sponsored health plans on the need for such exemptions.
    • To explore the intersection of healthcare policy, antitrust law, and market competition.

    Main Methods:

    • Review of current antitrust legislation and proposed amendments.
    • Analysis of market trends in provider-sponsored health plans.

    Related Experiment Videos

  • Comparative assessment of physician group structures and their market power.

    • Main Results:

    • The proliferation of provider-sponsored health plans may offer physicians alternative avenues for market participation.
    • Existing antitrust frameworks may be adaptable to the current healthcare market without specific physician exemptions.
    • Physician groups may already possess sufficient market leverage through integrated care models.

    Conclusions:

    • The necessity of broad antitrust exemptions for physicians is questionable in light of market evolution.
    • Policy discussions should consider the dynamic nature of healthcare delivery and competition.
    • Alternative strategies for physician collaboration and market engagement may mitigate the need for legislative changes to antitrust laws.